{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:14:59Z","timestamp":1758636899684},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00105-021-04843-z","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T14:02:47Z","timestamp":1623679367000},"page":"586-594","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Einfluss der LAight-Therapie auf die Versorgung der Acne inversa"],"prefix":"10.1007","volume":"72","author":[{"given":"Sophia","family":"Zimmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyra","family":"Basien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"von Stebut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"issue":"8","key":"4843_CR1","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/ced.12933","volume":"41","author":"C Dessinioti","year":"2016","unstructured":"Dessinioti\u00a0C, Zisimou\u00a0C, Tzanetakou\u00a0V et al (2016) Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a\u00a0prospective study and 1\u2011year follow-up. Clin Exp Dermatol 41(8):852\u2013857","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"4843_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","volume":"62","author":"A Grant","year":"2010","unstructured":"Grant\u00a0A, Gonzalez\u00a0T, Montgomery\u00a0MO, Cardenas\u00a0V, Kerdel\u00a0FA (2010) Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a\u00a0randomized, double-blind, placebo-controlled crossover trial. J\u00a0Am Acad Dermatol 62(2):205\u2013217","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"4843_CR3","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/bjd.14418","volume":"174","author":"JR Ingram","year":"2016","unstructured":"Ingram\u00a0JR, Woo\u00a0PN, Chua\u00a0SL, Ormerod\u00a0AD, Desai\u00a0N, Kai\u00a0AC, Hood\u00a0K, Burton\u00a0T, Kerdel\u00a0F, Garner\u00a0SE, Piguet\u00a0V (2016) Interventions for hidradenitis suppurativa: a\u00a0Cochrane systematic review incorporating GRADE assessment of evidence quality. Br J Dermatol 174(5):970\u2013978","journal-title":"Br J Dermatol"},{"key":"4843_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa1504370","volume":"375","author":"AB Kimball","year":"2016","unstructured":"Kimball\u00a0AB, Okun\u00a0MM, Williams\u00a0DA et\u00a0al (2016) Two phase 3 trials of adalimumab for hidradenitis suppurativa. N\u00a0Engl J Med 375:422\u2013434","journal-title":"N Engl J Med"},{"issue":"12","key":"4843_CR5","doi-asserted-by":"publisher","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","volume":"157","author":"AB Kimball","year":"2012","unstructured":"Kimball\u00a0AB, Kerdel\u00a0F, Adams\u00a0D, Mrowietz\u00a0U, Gelfand\u00a0JM, Gniadecki\u00a0R, Prens\u00a0EP, Schlessinger\u00a0J, Zouboulis\u00a0CC, van der Zee\u00a0HH, Rosenfeld\u00a0M, Mulani\u00a0P, Gu\u00a0Y, Paulson\u00a0S, Okun\u00a0M, Jemec\u00a0GB (2012) Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a\u00a0parallel randomized trial. Ann Intern Med 157(12):846\u2013855","journal-title":"Ann Intern Med"},{"issue":"1","key":"4843_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000455236","volume":"3","author":"N Kluger","year":"2017","unstructured":"Kluger\u00a0N, Ranta\u00a0M, Serlachius\u00a0MM (2017) The burden of hidradenitis suppurativa in a\u00a0cohort of patients in southern Finland: a pilot study. Skin Appendage Disord 3(1):20\u201327","journal-title":"Skin Appendage Disord"},{"issue":"5","key":"4843_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000508787","volume":"236","author":"G Kokolakis","year":"2020","unstructured":"Kokolakis\u00a0G, Wolk\u00a0K, Schneider-Burrus\u00a0S, Kalus\u00a0S, Barbus\u00a0S, Gomis-Kleindienst\u00a0S, Sabat\u00a0R (2020) Delayed diagnosis of hidradenitis suppurativa and its effect on patients and healthcare system. Dermatology 236(5):421\u2013430","journal-title":"Dermatology"},{"issue":"12","key":"4843_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11916-017-0647-3","volume":"21","author":"ZS Patel","year":"2017","unstructured":"Patel\u00a0ZS, Hoffman\u00a0LK, Buse\u00a0DC, Grinberg\u00a0AS, Afifi\u00a0L, Cohen\u00a0SR, Lowes\u00a0MA, Seng\u00a0EK (2017) Pain, psychological comorbidities, disability, and impaired quality of life in hidradenitis suppurativa [corrected]. Curr Pain Headache Rep 21(12):49","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"4843_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","volume":"6","author":"R Sabat","year":"2020","unstructured":"Sabat\u00a0R, Jemec\u00a0GBE, Matusiak \u0141, Kimball\u00a0AB, Prens\u00a0E, Wolk\u00a0K (2020) Hidradenitis suppurativa. Nat Rev Dis Primers 6(1):18","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"4843_CR10","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1038\/s41598-019-41322-x","volume":"9","author":"J Seok","year":"2019","unstructured":"Seok\u00a0J, Kim\u00a0JH, Kim\u00a0JM et al (2019) Effects of intradermal radiofrequency treatment and intense pulsed light therapy in an acne-induced rabbit ear model. Sci Rep 9(1):5056","journal-title":"Sci Rep"},{"key":"4843_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2019.1677842","volume":"17","author":"S Wilden","year":"2019","unstructured":"Wilden\u00a0S, Friis\u00a0M, Tuettenberg\u00a0A, Staubach-Renz\u00a0P, Wegner\u00a0J, Grabbe\u00a0S, von Stebut\u00a0E (2019) Combined treatment of hidradenitis suppurativa with intense pulsed light (IPL) and radiofrequency (RF). J\u00a0Dermatolog Treat 17:1\u20138","journal-title":"J Dermatolog Treat"},{"key":"4843_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","volume":"56","author":"P Wolkenstein","year":"2007","unstructured":"Wolkenstein\u00a0P, Loundou\u00a0A, Barrau\u00a0K et\u00a0al (2007) Quality of life impairment in hidradenitis suppurativa: a\u00a0study of 61\u00a0cases. J\u00a0Am Acad Dermatol 56:621\u2013623","journal-title":"J Am Acad Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04843-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04843-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04843-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T14:06:31Z","timestamp":1624889191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04843-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["4843"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04843-z","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,14]]},"assertion":[{"value":"18 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Zimmer, K.\u00a0Basien und E.\u00a0von Stebut geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Alle beschriebenen Untersuchungen am Menschen oder an menschlichem Gewebe wurden mit Zustimmung der zust\u00e4ndigen Ethikkommission, im Einklang mit nationalem Recht sowie gem\u00e4\u00df der Deklaration von Helsinki von 1975 (in der aktuellen, \u00fcberarbeiteten Fassung) durchgef\u00fchrt. Von allen beteiligten Patienten liegt eine Einverst\u00e4ndniserkl\u00e4rung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}